Skip to main content
Premium Trial:

Request an Annual Quote

Welcome to the New GT


Welcome to the New GT


I like to think that I am not unlike other people in my aversion to change. We rearranged the order of our mailboxes here in the office more than a year ago and to this day I catch myself checking someone else’s mail.

Sometimes change is good. And on rare occasions, change is terrific. I hope that when you finish perusing this issue of the magazine, you’ll agree that this is a great example of how positive change can be. As you know, we’ve been planning a number of alterations based on tremendous amounts of helpful feedback from you, our readers. Thanks to you, now more than ever we’re the integrated biology magazine you find indispensable.

First off, check out our newest pages, which will appear in every issue. Peer Review is a compilation of recent scientific papers of note recommended by readers like yourself — we like to think of it as a kind of journal club designed to save you time by highlighting only the most essential papers you need to read. Another newbie, Upcoming Events, is a calendar page covering the next few months. While several magazines list conferences, ours adds to the mix with abstract and program deadlines, workshops, seminars, and user groups.

Some other pages have gotten a facelift. Our readers’ tips page will go by the new name “Lab Notebook” and now focuses on a specific technical question. You no doubt remember our newsletter pages, where we ran an edited version of a story from each of our newsletters. Based on your feedback, we narrowed that to your five favorite technology areas — bioinformatics, microarrays, pharmacogenomics, proteomics, and RNAi — and changed the format to a news roundup in each category. In what we’re calling our “spotlight” pages, you’ll now find a main news story as well as several news blips, patent information, and other data pertinent to each of the tech areas. As for other changes, our case-study IT solutions page is going by the new name “Brute Force” and our Pattern Recognition data page will have a strong funding focus. Perhaps most importantly, our much-requested humor page is back where it belongs — don’t miss the Blunt End on p. 50.

Kudos to our design team for making everything look so good. Enjoy the issue, and let me know what you think. I’ll be here in New York, checking the wrong mailbox and otherwise recovering from all of this change.


Meredith W. Salisbury, Editor


What do you think of Genome Technology? Let me know how we’re doing by e-mailing me at [email protected] or by calling me at +1.212.651.5635.


Next Month in GT


Don’t miss these stories in the November/December issue:


Tech Transfer

How good is your technology transfer office? And how can you make sure that your inventions become as successful as they can? Our guide to tech transfer will look at some of the biggest academic licensing offices out there to let you in on how the experts do things. We’ll also include listings of technology currently being offered for license by tech transfer offices as well as tips from and for scientists on navigating the process.


Pharmacogenomics and Personalized Medicine

We’re entering the era of personalized medicine — and some organizations are getting there faster than others. GT takes you on a tour of who’s doing what to bring genomics from benchside to bedside; we’ll survey hospitals and clinical research groups to find out how far along these fields are, and when we can expect to see results. We’ll also talk to experts for better explanations of these concepts and how systems biology researchers are starting to have an impact in the medical arena.


The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.